Simon Frost

Title: Simon Frost: Innovator in Neurological Gene Therapy

Introduction

Simon Frost is an accomplished inventor based in Washington, DC. He has made significant contributions to the field of gene therapy, particularly in the treatment of neurological disorders. His innovative work has led to the development of a unique patent that addresses critical challenges in the central nervous system.

Latest Patents

Simon Frost holds a patent for "AAV-mediated delivery of ATP1A3 genes to the central nervous system." This invention relates to a transgenic vector designed for transducing cells within a mammal's central nervous system (CNS) and facilitating the transgenic expression of a protein. The transgenic vector comprises a virus-derived vector, a nucleic acid sequence encoding the protein, and an endogenous ATP1A3 promoter sequence. Additionally, the invention includes a composition featuring a recombinant AAV vector that contains a nucleic acid sequence encoding an ATP1A3 protein, which is compatible with administration into the CNS. Furthermore, the patent outlines methods for treating subjects with neurological disorders linked to mutations in the ATP1A3 gene and for delivering transgenic ATP1A3 DNA to the CNS through the administration of the recombinant AAV vector.

Career Highlights

Throughout his career, Simon Frost has worked with notable organizations such as Hope for Annabel and Cure AHC, Inc. His experience in these companies has allowed him to collaborate with other professionals in the field and contribute to advancements in neurological research.

Collaborations

Simon has collaborated with talented individuals, including Natalia Morsci and Neil Hackett. These partnerships have enriched his work and fostered innovation in gene therapy.

Conclusion

Simon Frost is a pioneering inventor whose work in gene therapy has the potential to transform the treatment of neurological disorders. His patent for AAV-mediated delivery of ATP1A3 genes exemplifies his commitment to advancing medical science.